13 completed, 2 active not recruiting, 2 unknown, 1 enrolling by invitation. 18 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 18 | Completed 13, Active not recruiting 2, Unknown 2, Enrolling by invitation 1 |
Follow adacel: new trials by email Literature Review of adacel trials Research Report on adacel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ESCUDDO Long Term Follow Up Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Recombinant Human Papillomavirus Nonavalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Malignant Neoplasm | Phase 4 | Enrolling by invitation | National Cancer Institute (NCI) | 13700 | 2026-08-11 | 2026-09-22 |
| Maternal Determinants of Infant Immunity to Pertussis Triaxis® (Pertussis-containing vaccine), Vaxelis® (Pertussis-containing vaccine) - Vaccination; Infection, Maternal-Fetal Relations | Phase 4 | Completed | Centre Hospitalier Universitaire Saint Pierre | 200 | 2023-09-12 | 2026-01-13 |
| Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women Adacel (Tdap) - dTap Vaccine | Phase 4 | Completed | Farzanah Laher | 511 | 2022-03-08 | 2026-05-15 |
| Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 5000 | 2022-03-01 | 2026-10-22 |
| Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 27945 | 2017-11-29 | 2025-09-04 |
| Adacel® Booster Vaccination for CMI Assay Development Adacel® - Pertussis | Phase 4 | Completed | Dalhousie University | 10 | 2017-07-12 | 2020-09-10 |
| Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®), Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®) - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 423 | 2012-06-01 | 2016-03-02 |
| Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine, Tetanus and Diphtheria Toxoids Adsorbed For Adult Use - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 1330 | 2011-11-01 | 2022-04-28 |
| Study of Adacel® Vaccine Administered to Persons 10 Years of Age Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi | 1302 | 2011-03-01 | 2016-04-08 |
| Post Marketing Surveillance for ADACEL™ in South Korea ADACEL™:Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 659 | 2010-06-01 | 2022-04-28 |
| An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster Td5ap, Td1aP - Tetanus, Diphtheria | Phase 4 | Unknown | Swedish Institute for Infectious Disease Control | 400 | 2009-04-01 | 2010-06-07 |
| Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®) - Pertussis, Tetanus | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 769 | 2008-06-01 | 2014-04-30 |
| A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed, DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed - Pertussis, Tetanus | Phase 4 | Completed | Sanofi | 1564 | 2007-03-01 | 2012-10-19 |
| Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine Tetanus-diphtheria-acellular pertussis (Tdap) vaccine - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 545 | 2006-08-01 | 2013-12-04 |
| The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients Tetanus and Diphtheria Toxoids Adsorbed Combined with Acellular Pertussis (Adacel) - Pertussis | Phase 4 | Unknown | Queen Elizabeth II Health Sciences Centre | 10 | 2006-07-01 | 2007-10-23 |
| Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX® ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed, BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed - Pertussis, Tetanus | Phase 4 | Completed | Sanofi | 647 | 2006-05-01 | 2012-10-05 |
| Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine COVAXIS™: Tetanus, diphtheria, acellular 5-component pertussis, or + inactivated poliovirus vaccine (REPEVAX®) - Pertussis, Diphtheria | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 215 | 2006-03-01 | 2016-04-14 |
| Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine T dap + Meningococcal Polysaccharide Diphtheria Toxoid Conj., Tdap + Meningococcal Polysaccharide Diphtheria Toxoid Conj., Meningococcal Polysaccharide Diphtheria Toxoid Conj. + T dap - Meningitis, Meningococcemia | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 1345 | 2005-04-01 | 2014-02-14 |
Whooping Cough (15) · Diphtheria (11) · Tetanus (11) · Papillomavirus Infections (2) · Infections (1) · Meningitis (1) · Meningococcal Infections (1) · Poliomyelitis (1)
Sanofi Pasteur, a Sanofi Company (7) · National Cancer Institute (NCI) (3) · Sanofi (3) · Centre Hospitalier Universitaire Saint Pierre (1) · Dalhousie University (1) · Farzanah Laher (1) · Queen Elizabeth II Health Sciences Centre (1) · Swedish Institute for Infectious Disease Control (1)
United States (7) · Canada (4) · Costa Rica (3) · Belgium (1) · Germany (1) · South Africa (1) · South Korea (1) · Sweden (1)
Aimee R Kreimer (2) · Aimee Kreimer (1) · Eva Netterlid (1) · Leif Gothefors, Prof. em. (1) · Monique L MacFarlane Conrad, MSc (1) · Scott A Halperin, MD (1) · Shelly McNeil, MD (1)
PMID 41276263, PMID 20616762, PMID 22115634, PMID 25008903, PMID 25230939, PMID 26057135, PMID 29438562, PMID 29573876, PMID 31301919, PMID 31945015, PMID 32078808, PMID 33857679, PMID 34857420, PMID 37773052, PMID 41337735
2008 (1)